Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

eu_flag

UK Government commits to funding EU research projects after Brexit

August 15, 2016 Manufacturing and Production, Research and Development brexit, research

Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …
News
top_ten

Top ten stories in the pharmaceutical industry this week

August 15, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest stories, pharma, pharmafile, stories of the week, top 10

It’s Monday and we’re just getting back to it after a busy week in pharma. Unfortunately, it was mostly bad …
News
shutterstock_76507048

Acute coronary syndrome market to grow to over $12 billion by 2022

August 15, 2016 Research and Development, Sales and Marketing GlobalData, acute coronary syndrome

The acute coronary syndrome (ACS) market is forecast to rise from $7.8 billion in 2015 to $12.1 billion by 2022 …
News
vaccination

Sanofi launches dengue immunisation program in Brazil

August 15, 2016 Research and Development, Sales and Marketing Brazil, Sanofi, Sanofi Pasteur, Vaccine, dengue, immunisation, vaccines

Sanofi has announced that it has initiated the first dengue immunisation public program in the Americas, with 500,000 individuals set …
News
abbvie_0

Study shows promise for Venclexta in acute myelogenous leukaemia

August 12, 2016 Research and Development, Sales and Marketing AbbVie, Genentech, Roche, Venclexta, venetoclax

A study published in Cancer Discovery, the journal of the American Association for Cancer Research, suggests that Vencletxa (venetoclax) is …
News
clinical_trial-web

Promising results for new type 2 diabetes management procedure

August 12, 2016 Research and Development, Sales and Marketing Fractyl, Revita, diabetes, type 2 diabetes

Fractyl Laboratories has revealed data from its first-in-human study of Revita duodenal mucosal resurfacing (Revita DMR), a new 60-minute, non-surgical …
News

Ashfield publishes a guide to Patient Support Programmes: Ten steps to success

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing

The priorities of Pharma and healthcare organisations are better aligned as a result of the industry’s increased efforts to put …
News
Press release
cdc1

Number of babies born with opioid dependence has tripled in US, says CDC report

August 12, 2016 Medical Communications, Research and Development CDC, addicted, babies, opioid dependence, opioids

A new report from the Centers for Disease Control and Prevention (CDC) has highlighted a sharp increase in the number …
News

Novartis admits employees gave kickbacks to doctors in South Korea

August 12, 2016 Medical Communications, Research and Development Novartis, kickbacks, south korea

Novartis has confirmed that six employees in South Korea gave kickbacks to doctors, as the current and former employees face …
News
laboratory-testing-az

Advaxis follows up Amgen deal with Phase IIa cancer trial success

August 12, 2016 Medical Communications, Research and Development Advaxis, immunotherapy. cancer. Amgen

Advaxis, a US biotech in cancer immunotherapy development, has announced that its lead immunotherapy product axalimogene filolisbac (AXAL) has hit …
News
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016 Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …
News
shutterstock_92671375

Valeant under criminal investigation

August 11, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Philidor, Valeant, investigation

Valeant Pharmaceuticals International is currently under investigation by the US attorney’s office in Manhattan over suspicions that the firm intentionally …
News

FDA accepts Marathon’s Duchenne drug for priority review

August 11, 2016 Research and Development, Sales and Marketing Duchenne Muscular Dystrophy, FDA, deflazacort, marathon, marathon pharmaceuticals

Marathon Pharmaceuticals has announced that the US Food and Drug Administration (FDA) has accepted and granted a priority review for …
News
chemo-web

Heron Therapeutics gets FDA approval for chemotherapy-induced nausea drug

August 11, 2016 Research and Development, Sales and Marketing FDA, chemotherapy-induced nausea, granisetron, heron therapeutics, sustol

Heron Therapeutics has announced that it has received US Food and Drug Administration (FDA) approval for Sustol (granisetron) for the …
News
chronos_therapeutics

Chronos Therapetics strengthens management with two new vice presidents

August 10, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Private biotech Chronos Therapeutics has announced two new additions to its management team; Dr Fraser Murray and Dr Timonthy Schulz-Utermoehl …
Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026